Cell death and aging may drive kidney scarring through a metabolic loop
Two processes in kidney cells—necroptosis (a type of cell death) and senescence (cellular aging)—may work together to cause kidney scarring that current drugs cannot reverse. They form a self-amplifying cycle involving mitochondrial DNA and metabolic changes.
Why it matters: Understanding this mechanism could guide new combination therapies for kidney disease that current treatments fail to address.
Keep in mind: This is a review of existing research; it identifies a proposed mechanism but provides no new human or animal data proving this pathway causes kidney scarring in patients.
AI-assisted explanation based on the supplied abstract. Read the linked source for full context.
What this changes
The finding has not established an approved change to our evidence assessment.
Source date: Sep 3, 2026 · Discovered: Sep 18, 2026 · Assessed: — · Research update
What it does not prove
- Limitations have not yet been verified. Read the primary source.
Extracted from supplied source material; model confidence is not a measured probability of correctness.
Study details
- Design
- Systematic review
- Sample size
- —
- Duration
- —
- Population
- Renal tubular epithelial cells and interstitial fibroblasts in the context of chronic kidney disease progressing to tubulointerstitial fibrosis
- Primary outcome
- Mechanistic characterization of the mtDNA-cGAS-STING-PFKFB3 axis in necroptosis-senescence crosstalk during tubulointerstitial fibrosis
- Effect size
- —
- Significance
- Not reported
- Journal
- Frontiers in Medicine
- Published
- Sep 3, 2026
Sources
Primary source
- Frontiers in medicine ↗Peer reviewed
Assessment history
Discussion (0)
One thread per scientific event, no matter how many outlets covered it.
No comments yet
Be the first to weigh in on this evidence.